Maria Baldo
Medical · New York, NYNPI 1902946288
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $29,302 of the $40,037 with a category attached, or 73.2%. Sanofi-aventis U.S. LLC accounts for 96.5% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2023 at $21,722 and has fallen 76.4% since, to $5,136 in 2025. Among medical clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 122 payments — averaging $328.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi-aventis U.S. LLC$39K
- Incyte Corporation$396
- Novartis$310
- Takeda Pharmaceuticals U.S.A., Inc.$172
- Servier Pharmaceuticals LLC$99
- Daiichi Sankyo Inc.$74
- plus $348 from 11 others
What the payments were for
- Speaking & faculty fees$29,30273%
- Travel & lodging$7,19318%
- Food & beverage$3,4439%
- Education$990%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi-aventis U.S. LLC | 82 | $38,638 |
| Incyte Corporation | 5 | $396 |
| Novartis | 12 | $310 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $172 |
| Servier Pharmaceuticals LLC | 5 | $99 |
| Daiichi Sankyo Inc. | 3 | $74 |
| Biolinerx USA, Inc. | 1 | $69 |
| Rigel Pharmaceuticals, Inc. | 1 | $44 |
| Sobi, Inc | 2 | $36 |
| Astellas Pharma US Inc | 1 | $31 |
| Azurity Pharmaceuticals, Inc. | 1 | $27 |
| Blueprint Medicines Corporation | 1 | $26 |
| AstraZeneca | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $25 |
| Morphosys, US Inc. | 1 | $23 |
| Sanofi | 1 | $22 |
| Pharmaessentia USA Corporation | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$40,037 in reported general payments places this provider in the 95th percentile of 2,395 medical providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Entecavir | 22 | $3,747 |
| ValacyclovirValacyclovir Hcl | 37 | $1,676 |
| Pantoprazole Sodium | 11 | $65 |
| Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim | 15 | $41 |
Paid to pharmacies, not to this prescriber.
Other medical in New York
- Michele Kissous-HuntNew York$246K
- Laura MaroldoNew York$126K
- Maureen ThyneNew York$109K
- Helen AdamsNew York$87K
- Hailey BrickmanNew York$82K
- Michael QuerijeroNew York$32K
- Meiting LiangNew York$25K
- Karina SodenNew York$23K
- Noah KiefferNew York$19K
- Monica HarilallNew York$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.